Unlikely to cause harm — often a labeling or packaging issue.
Failed Impurities/Degradation Specifications; out of specification for Related Compound
| Brand name | CANDESARTAN CILEXETIL |
| Generic name | CANDESARTAN CILEXETIL |
| Active ingredient(s) | CANDESARTAN CILEXETIL |
| Distributed by / for | Mylan Pharmaceuticals Inc., Morgantown, WV 26505 |
| NDC | 0378-3231-93 |
| Full product label | Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93 |
| Recalling firm | Viatris |
| Distribution | Product was distributed nationwide. |
| Quantity | 21,094 |
| Recall initiated | 2021-09-13 |
| Report date | 2021-09-22 |
| Recall completed | 2022-04-28 |
| Recall number | D-0798-2021 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Morgantown WV United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗